前言：目的：介绍治疗原发性肺动脉高压的吸入性伊洛前列素。
Objective: To introduce inhaled iloprost for the treatment of primary pulmonary hypertension.
这项研究在任何时点以及整个试验中显示伊洛前列素和安慰剂组之间疗效并无显著差别。
No significant differences in efficacy were found between iloprost and placebo, either overall or at any time point in the study.
结果和结论：吸入性伊洛前列素治疗可以降低肺血管阻力和延缓原发性肺动脉高压的进程。
Results and Conclusion: Inhaled iloprost can reduce pulmonary vascular resistance and delay the development of primary pulmonary hypertension.
应用推荐